261 related articles for article (PubMed ID: 10208919)
21. Coexpression of the adenovirus 12 E1B 55 kDa oncoprotein and cellular tumor suppressor p53 is sufficient to induce metaphase fragility of the human RNU2 locus.
Liao D; Yu A; Weiner AM
Virology; 1999 Feb; 254(1):11-23. PubMed ID: 9927570
[TBL] [Abstract][Full Text] [Related]
22. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
23. Augmentation by IL-1 alpha of tumor necrosis factor-alpha cytotoxicity in cells transfected with adenovirus E1A.
Tsuji Y; Ninomiya-Tsuji J; Torti SV; Torti FM
J Immunol; 1993 Mar; 150(5):1897-907. PubMed ID: 8436824
[TBL] [Abstract][Full Text] [Related]
24. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
25. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
[TBL] [Abstract][Full Text] [Related]
26. Structural determinants in adenovirus 12 E1A involved in the interaction with C-terminal binding protein 1.
Molloy DP; Barral PM; Bremner KH; Gallimore PH; Grand RJ
Virology; 2000 Nov; 277(1):156-66. PubMed ID: 11062046
[TBL] [Abstract][Full Text] [Related]
27. The NH(2)-terminal and conserved region 2 domains of adenovirus E1A mediate two distinct mechanisms of tumor suppression.
Deng J; Kloosterbooer F; Xia W; Hung MC
Cancer Res; 2002 Jan; 62(2):346-50. PubMed ID: 11809676
[TBL] [Abstract][Full Text] [Related]
28. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
29. Recruitment of TRRAP required for oncogenic transformation by E1A.
Deleu L; Shellard S; Alevizopoulos K; Amati B; Land H
Oncogene; 2001 Dec; 20(57):8270-5. PubMed ID: 11781841
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.
Yew PR; Berk AJ
Nature; 1992 May; 357(6373):82-5. PubMed ID: 1533443
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus early region 1A protein binds to mammalian SUG1-a regulatory component of the proteasome.
Grand RJ; Turnell AS; Mason GG; Wang W; Milner AE; Mymryk JS; Rookes SM; Rivett AJ; Gallimore PH
Oncogene; 1999 Jan; 18(2):449-58. PubMed ID: 9927201
[TBL] [Abstract][Full Text] [Related]
32. Rb function is required for E1A-induced S-phase checkpoint activation.
Nemajerova A; Talos F; Moll UM; Petrenko O
Cell Death Differ; 2008 Sep; 15(9):1440-9. PubMed ID: 18451867
[TBL] [Abstract][Full Text] [Related]
33. [The p21(WAF1) cyclin-kinase inhibitor: in vivo interaction with E1A adenoviral Ad2 and Ad12 oncoproteins].
Timofeev OV; Pospelov VA
Tsitologiia; 2003; 45(11):1109-18. PubMed ID: 14989150
[TBL] [Abstract][Full Text] [Related]
34. Induction of neuronal and tumor-related genes by adenovirus type 12 E1A.
Guan H; Williams JF; Ricciardi RP
J Virol; 2009 Jan; 83(2):651-61. PubMed ID: 18987153
[TBL] [Abstract][Full Text] [Related]
35. [A new human cellular protein AUP1. I. In vitro interaction of AUP1 with adenoviral proteins E4ORF3 and E1A].
Karpisheva KV; Tauber B; Kisliakova TV; Dobner T
Tsitologiia; 2002; 44(9):830-8. PubMed ID: 12534236
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S
Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416
[TBL] [Abstract][Full Text] [Related]
37. Functional interactions within adenovirus E1A protein complexes.
Barbeau D; Charbonneau R; Whalen SG; Bayley ST; Branton PE
Oncogene; 1994 Feb; 9(2):359-73. PubMed ID: 8290250
[TBL] [Abstract][Full Text] [Related]
38. Independent transformation activity by adenovirus-5 E1A-conserved regions 1 or 2 mutants.
Svensson C; Bondesson M; Nyberg E; Linder S; Jones N; Akusjärvi G
Virology; 1991 Jun; 182(2):553-61. PubMed ID: 1827227
[TBL] [Abstract][Full Text] [Related]
39. Induction of a complex between rasGAP and a novel 110 kD protein is required for immortalization of primary epithelial cells by the E1A 12S oncoprotein of adenovirus.
Gopalakrishnan S; Fischer RS; Quinlan MP
Oncogene; 1996 Dec; 13(12):2659-69. PubMed ID: 9000140
[TBL] [Abstract][Full Text] [Related]
40. Functional importance of complex formation between the retinoblastoma tumor suppressor family and adenovirus E1A proteins as determined by mutational analysis of E1A conserved region 2.
Corbeil HB; Branton PE
J Virol; 1994 Oct; 68(10):6697-709. PubMed ID: 8084002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
